Exicure Delays Q3 10-Q, Citing Accounting Review of Assets and Liabilities
XCUR sits 38% above its 52-week low of $0.777 on light trading volume (0.2× avg).
Summary
Exicure filed a Form 12b-25 late-filing notice for its Q3 2026 10-Q, saying it needs more time to finish reviewing the accounting for certain assets and liabilities. It expects to file within the five-day extension window. This lands on top of an already fragile setup: the last 10-Q showed cash down to $1.7M, stockholders' equity below Nasdaq's minimum, and a going concern warning, and the company has an extension until December 2, 2026 to regain compliance. Accounting delays at a company this small, with a going concern flag, raise the risk of restatement or fresh control issues. The December 2 shareholder vote on authorizing up to $10 million of private placements is the next scheduled item, and the 10-Q is due within days under the extension.
At the time of this announcement, XCUR was trading at $1.07 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7M. The 52-week trading range was $0.78 to $9.48. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.